Bortezomib With Melphalan and Prednisone for Multiple Myeloma

NCT00734149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Melphalan
DRUG: Prednisone

Sponsor

Duke University